263 related articles for article (PubMed ID: 28319199)
1. A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.
Clegg LE; Mac Gabhann F
PLoS Comput Biol; 2017 Mar; 13(3):e1005445. PubMed ID: 28319199
[TBL] [Abstract][Full Text] [Related]
2. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
Mac Gabhann F; Popel AS
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
[TBL] [Abstract][Full Text] [Related]
3. Systems Pharmacology of VEGF165b in Peripheral Artery Disease.
Clegg LE; Ganta VC; Annex BH; Mac Gabhann F
CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):833-844. PubMed ID: 29193887
[TBL] [Abstract][Full Text] [Related]
4. Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells.
Sarabipour S; Kinghorn K; Quigley KM; Kovacs-Kasa A; Annex BH; Bautch VL; Mac Gabhann F
PLoS Comput Biol; 2024 Feb; 20(2):e1011798. PubMed ID: 38324585
[TBL] [Abstract][Full Text] [Related]
5. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
6. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
7. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle.
Mac Gabhann F; Popel AS
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H459-74. PubMed ID: 16980341
[TBL] [Abstract][Full Text] [Related]
8. A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
Wu FT; Stefanini MO; Mac Gabhann F; Popel AS
PLoS One; 2009; 4(4):e5108. PubMed ID: 19352513
[TBL] [Abstract][Full Text] [Related]
9. VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.
Sarkar J; Luo Y; Zhou Q; Ivakhnitskaia E; Lara D; Katz E; Sun MG; Guaiquil V; Rosenblatt M
PLoS One; 2022; 17(7):e0269818. PubMed ID: 35862373
[TBL] [Abstract][Full Text] [Related]
10. Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model.
Clegg LW; Mac Gabhann F
PLoS Comput Biol; 2015 Jun; 11(6):e1004158. PubMed ID: 26067165
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.
Peach CJ; Mignone VW; Arruda MA; Alcobia DC; Hill SJ; Kilpatrick LE; Woolard J
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690653
[TBL] [Abstract][Full Text] [Related]
12. VEGF-A121a binding to Neuropilins - A concept revisited.
Sarabipour S; Mac Gabhann F
Cell Adh Migr; 2018 May; 12(3):204-214. PubMed ID: 29095088
[TBL] [Abstract][Full Text] [Related]
13. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
[TBL] [Abstract][Full Text] [Related]
14. VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.
Bruns AF; Bao L; Walker JH; Ponnambalam S
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1193-7. PubMed ID: 19909245
[TBL] [Abstract][Full Text] [Related]
15. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A
Pang V; Bates DO; Leach L
Clin Sci (Lond); 2017 Dec; 131(23):2763-2775. PubMed ID: 29054861
[TBL] [Abstract][Full Text] [Related]
17. Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells.
Peach CJ; Kilpatrick LE; Friedman-Ohana R; Zimmerman K; Robers MB; Wood KV; Woolard J; Hill SJ
Cell Chem Biol; 2018 Oct; 25(10):1208-1218.e5. PubMed ID: 30057299
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
19. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.
Mac Gabhann F; Popel AS
PLoS Comput Biol; 2006 Dec; 2(12):e180. PubMed ID: 17196035
[TBL] [Abstract][Full Text] [Related]
20. Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model.
Mac Gabhann F; Popel AS
Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2851-60. PubMed ID: 15708957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
